The FDA declined to approve a biologics license application for Galderma’s relabotulinumtoxinA, citing manufacturing and ...
AMA recently reiterated its call for Congress to pass several reforms that would increase physician payment and improve ...
The FDA has approved a label expansion for Casgevy to include patients aged 2 years and older with sickle cell disease and ...
Adults with type 2 diabetes who were provided medically tailored healthy meals and lifestyle counseling for 6 months had a ...
A new CMS proposed rule would reduce the burden of prior authorizations by further shortening payer decision timeframes and ...
Storm chasing is often described as hours of boredom intermixed with moments of sheer terror. I fear that that metaphor is ...
Cardiology societies unveiled the new universal definition of heart failure, with a new focus on early prevention of HF and ...
Wearable devices accelerated detection of a common and potentially life-threatening complication among patients with multiple ...
Adults and children with eczema who received care via a team-based connected telehealth model incorporating primary care ...
Even when he was a child, Sean Ianchulev, MD, MPH, wanted to fix things and make them better.When he emigrated to the United ...
Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that expand ...
An AI model using electronic health record data helped researchers narrow down who should be screened for primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results